Table 5.

Circulating Tumor Cells (CTCs) Evaluated by FACS (n = 10)

Subject	Total # of CTCs (Veridex)	Total # of CTCs (FACS)	Total # of ASG positive CTCs (FACS) (%)	Total # of EPCAM positive CTCs (FACS) (%)	Baseline PSA (ug/L)	# doses	Duration on study (days)
1	0	195	180 (92)	31 (16)	2.35	1	21
2	0	127	127 (100)	94 (74)	24.2	1	23
3	71	186	59 (32)	171 (92)	1219.8	1	43
4	139	646	40 (6)	636 (98)	371.62	2	57
5	2	623	610 (98)	29 (5)	234.84	3	77
6	1	10	9 (90)	9 (90)	114	3	78
7	61	138	113 (82)	30 (22)	2475.7	4	72
8	6	113	101 (89)	38 (34)	214	4	85
9	0	117	105(90)	24 (21)	74.5	4	85
10	0	61	61 (100)	3(5)	57.4	4	106